Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



COVID-19: The Catastrophe of Our Time

Md. Moinuddin Sheam, Shifath Bin Syed, Shital Kumar Barman, Md Rockybul Hasan, Dipak Kumar Paul, Rokibul Islam, Sudhangshu Kumar Biswas.




Abstract

The most discussed topic in today's world is COVID-19, an acute respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) because of its contagious transmission pattern, and morbimortality. The virus was originated by bats and in December 2019, first spread to humans by unknown intermediate species in Wuhan, China. The dramatic acceleration of the occurrence and death toll of COVID-19 with no potential medicine and vaccine are enough to explain its severity. This review summarizes multidisciplinary aspects of COVID-19, including origin, epidemiology, symptoms, transmission, pathogenicity and advances in the use of modern diagnostic procedures and methods. Further, we analyzed extensively for various therapeutic strategies, potential drug options with prospective vaccine candidates and challenges along the way. All data were accumulated through extensive study of recent peer-reviewed publications until May 23, 2020. Collectively, this review would help to shed light on different dimensions of this ongoing pandemic.

Key words: COVID-19; SARS-CoV-2; Therapeutics; Prospective Vaccines; Pathogenesis.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.